http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0308386-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 |
| filingDate | 1988-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1992-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0308386-B1 |
| titleOfInvention | New medical use |
| abstract | A method for improving the regeneration of transected peripheral nerves in mammals and man, by administering a sufficient amount of insulin-like growth factor 1 (IGF-1) to a mammalian or human host in need of such treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103370074-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103370074-B |
| priorityDate | 1987-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.